<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01304082</url>
  </required_header>
  <id_info>
    <org_study_id>2010-P-000533</org_study_id>
    <nct_id>NCT01304082</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the Effect of pH on Pain Upon Local Anesthetic Administration.</brief_title>
  <official_title>A Single-center, Randomized, Double-blind Clinical Study to Evaluate the Effect of pH on Pain Upon Local Anesthetic Administration.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      When one receives a local anesthetic, such as novocaine for a dental procedure, there is a
      burning painful sensation experienced upon injection of the local anesthetic. We are trying
      to understand the role of pH (how acidic a solution is) in the production of pain during
      local anesthetic administration. We hypothesize that less acidic solutions produce less
      burning. We also want to determine whether or not the pH of the solution affects the rate of
      onset of the local anesthesia. We will recruit subjects from patients who have a clinical
      indication for lumbar medial branch (LMB) nerve blocks, procedures frequently performed at
      the Massachusetts General Hospital Center for Pain Medicine. For each patient, three nerve
      blocks are administered at adjacent spinal levels, typically using either lidocaine or
      bicarbonate-buffered lidocaine as the local anesthetic. We will add a saline control as part
      of the research procedure and then provide lidocaine at the control location before
      continuing with the nerve blocks. This clinical procedure offers an ideal opportunity to
      compare the effects of the three solutions. There will be almost no deviation from the
      standard clinical procedure. After the injection of each solution, the pain score on
      administration of the medication will be recorded immediately. We will also provide a
      continuous stimulation (pin taps) after the local anesthetic injection and record when the
      patient experiences hypoesthesia (reduced sensation) and anesthesia (absent sensation).
      Finally, we will record the pain score upon reinsertion of a needle to mark the precise
      location (part of the clinical procedure) one minute after the local anesthetic injection.
      All data will be collected during the a single clinical visit.

      The study will conclude when 60 subjects have successfully been tested. Data will be reviewed
      annually.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient Enrollment
  </why_stopped>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rank-transformed Pain Score</measure>
    <time_frame>immediate, upon injection of each solution</time_frame>
    <description>Pain score upon injection of local anesthetic:
the pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rank-transformed Time (Seconds) Until Hypoesthesia</measure>
    <time_frame>0-180 seconds after each injection.</time_frame>
    <description>Rank-transformed time (seconds) until hypoesthesia will be assessed using a sensory stimulus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rank-transformed Time (Seconds) Until Anesthesia</measure>
    <time_frame>0-180 seconds after each injection</time_frame>
    <description>Rank-transformed time (seconds) until anesthesia will be assessed using a repeated sensory stimulus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rank-transformed Pain Score Upon Needle Stick.</measure>
    <time_frame>1 minute after each injection</time_frame>
    <description>Pain score upon needle stick:
The pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Local Anesthetics</condition>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>alkalinized lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>1 ml subcutaneous injection of 0.9% lidocaine, given once</description>
    <arm_group_label>lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>1 ml subcutaneous injection 0.9% sodium chloride, given once</description>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>alkalinized lidocaine</intervention_name>
    <description>1 ml subcutaneous injection of 0.9% lidocaine and 0.84% sodium bicarbonate</description>
    <arm_group_label>alkalinized lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients at MGH Center for Pain Medicine who have clinical indication for undergoing
             diagnostic medial branch block of nerves to facet joints.

        Exclusion Criteria:

          -  contraindication to the clinical procedure

          -  do not speak English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian J Wainger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2011</study_first_posted>
  <results_first_submitted>January 11, 2017</results_first_submitted>
  <results_first_submitted_qc>February 28, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 11, 2017</results_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Brian Wainger</investigator_full_name>
    <investigator_title>Instructor</investigator_title>
  </responsible_party>
  <keyword>pain pH local anesthetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>C, L, A</title>
          <description>control, lidocaine, alkalinized lidocaine</description>
        </group>
        <group group_id="P2">
          <title>C, A, L</title>
          <description>control, alkalinized lidocaine, lidocaine</description>
        </group>
        <group group_id="P3">
          <title>L, C, A</title>
          <description>lidocaine, control, alkalinized lidocaine</description>
        </group>
        <group group_id="P4">
          <title>A, C, L</title>
          <description>alkalinized lidocaine, control, lidocaine</description>
        </group>
        <group group_id="P5">
          <title>A, L, C</title>
          <description>alkalinized lidocaine, lidocaine, control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>First Intervention</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Second Intervention</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Third Intervention</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="8"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>All study participants</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>One participant was missing age.</population>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.5" lower_limit="44.5" upper_limit="62.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Pain Score</title>
          <description>This pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6" lower_limit="4" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rank-transformed Pain Score</title>
        <description>Pain score upon injection of local anesthetic:
the pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).</description>
        <time_frame>immediate, upon injection of each solution</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>normal saline: 1 ml subcutaneous injection 0.9% sodium chloride, given once</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>Lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine, given once</description>
          </group>
          <group group_id="O3">
            <title>Alkalinized Lidocaine</title>
            <description>alkalinized lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine and 0.84% sodium bicarbonate</description>
          </group>
        </group_list>
        <measure>
          <title>Rank-transformed Pain Score</title>
          <description>Pain score upon injection of local anesthetic:
the pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).</description>
          <units>rank</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rank-transformed pain score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.97" lower_limit="1.62" upper_limit="2.31"/>
                    <measurement group_id="O2" value="2.10" lower_limit="1.76" upper_limit="2.45"/>
                    <measurement group_id="O3" value="1.93" lower_limit="1.59" upper_limit="2.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to control</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0.138" lower_limit="-0.459" upper_limit="0.735"/>
                    <measurement group_id="O3" value="-0.034" lower_limit="-0.632" upper_limit="0.563"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to lidocaine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.138" lower_limit="-0.735" upper_limit="0.459"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="-0.172" lower_limit="-0.769" upper_limit="0.425"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis: Non-parametric Friedman ANOVA test on rank-transformed outcome with Bonferroni correction for pairwise comparisons.
Null hypothesis: No difference between the groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.7535</p_value>
            <p_value_desc>Bonferroni correction for pairwise comparisons</p_value_desc>
            <method>non-parametric Friedman ANOVA test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rank-transformed Time (Seconds) Until Hypoesthesia</title>
        <description>Rank-transformed time (seconds) until hypoesthesia will be assessed using a sensory stimulus</description>
        <time_frame>0-180 seconds after each injection.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>normal saline: 1 ml subcutaneous injection 0.9% sodium chloride, given once</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>Lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine, given once</description>
          </group>
          <group group_id="O3">
            <title>Alkalinized Lidocaine</title>
            <description>alkalinized lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine and 0.84% sodium bicarbonate</description>
          </group>
        </group_list>
        <measure>
          <title>Rank-transformed Time (Seconds) Until Hypoesthesia</title>
          <description>Rank-transformed time (seconds) until hypoesthesia will be assessed using a sensory stimulus</description>
          <units>rank</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rank-transformed time (s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.95" lower_limit="2.75" upper_limit="3.15"/>
                    <measurement group_id="O2" value="1.47" lower_limit="1.27" upper_limit="1.67"/>
                    <measurement group_id="O3" value="1.59" lower_limit="1.39" upper_limit="1.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to control</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="-1.48" lower_limit="-1.83" upper_limit="-1.13"/>
                    <measurement group_id="O3" value="-1.36" lower_limit="-1.71" upper_limit="-1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to lidocaine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.48" lower_limit="1.13" upper_limit="1.83"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0.121" lower_limit="-0.228" upper_limit="0.469"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis: Non-parametric Friedman ANOVA test on rank-transformed outcome with Bonferroni correction for pairwise comparisons.
Null hypothesis: No difference between the groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Bonferroni correction for pairwise comparisons</p_value_desc>
            <method>non-parametric Friedman ANOVA test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rank-transformed Time (Seconds) Until Anesthesia</title>
        <description>Rank-transformed time (seconds) until anesthesia will be assessed using a repeated sensory stimulus.</description>
        <time_frame>0-180 seconds after each injection</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>normal saline: 1 ml subcutaneous injection 0.9% sodium chloride, given once</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>Lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine, given once</description>
          </group>
          <group group_id="O3">
            <title>Alkalinized Lidocaine</title>
            <description>alkalinized lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine and 0.84% sodium bicarbonate</description>
          </group>
        </group_list>
        <measure>
          <title>Rank-transformed Time (Seconds) Until Anesthesia</title>
          <description>Rank-transformed time (seconds) until anesthesia will be assessed using a repeated sensory stimulus.</description>
          <units>rank</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rank-transformed time (s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.90" lower_limit="2.68" upper_limit="3.11"/>
                    <measurement group_id="O2" value="1.62" lower_limit="1.40" upper_limit="1.84"/>
                    <measurement group_id="O3" value="1.48" lower_limit="1.26" upper_limit="1.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to control</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="-1.28" lower_limit="-1.66" upper_limit="-0.90"/>
                    <measurement group_id="O3" value="-1.41" lower_limit="-1.79" upper_limit="-1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to lidocaine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" lower_limit="0.90" upper_limit="1.66"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="-0.14" lower_limit="-0.52" upper_limit="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis: Non-parametric Friedman ANOVA test on rank-transformed outcome with Bonferroni correction for pairwise comparisons.
Null hypothesis: No difference between the groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Bonferroni correction for pairwise comparisons</p_value_desc>
            <method>non-parametric Friedman ANOVA test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rank-transformed Pain Score Upon Needle Stick.</title>
        <description>Pain score upon needle stick:
The pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).</description>
        <time_frame>1 minute after each injection</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Normal Saline</title>
            <description>normal saline: 1 ml subcutaneous injection 0.9% sodium chloride, given once</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>Lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine, given once</description>
          </group>
          <group group_id="O3">
            <title>Alkalinized Lidocaine</title>
            <description>alkalinized lidocaine: 1 ml subcutaneous injection of 0.9% lidocaine and 0.84% sodium bicarbonate</description>
          </group>
        </group_list>
        <measure>
          <title>Rank-transformed Pain Score Upon Needle Stick.</title>
          <description>Pain score upon needle stick:
The pain score is a validated 11-point numeric rating scale in which patients rate pain between 0 (no pain) and 10 (worst pain imaginable).</description>
          <units>rank</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rank-transformed pain score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.72" lower_limit="2.50" upper_limit="2.95"/>
                    <measurement group_id="O2" value="1.64" lower_limit="1.41" upper_limit="1.86"/>
                    <measurement group_id="O3" value="1.64" lower_limit="1.41" upper_limit="1.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to control</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="-1.09" lower_limit="-1.48" upper_limit="-0.70"/>
                    <measurement group_id="O3" value="-1.09" lower_limit="-1.48" upper_limit="-0.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Difference compared to lidocaine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" lower_limit="0.70" upper_limit="1.48"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O3" value="0" lower_limit="-0.39" upper_limit="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis: Non-parametric Friedman ANOVA test on rank-transformed outcome with Bonferroni correction for pairwise comparisons.
Null hypothesis: No difference between the groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Bonferroni correction for pairwise comparisons</p_value_desc>
            <method>non-parametric Friedman ANOVA test</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Normal Saline</title>
          <description>1 ml subcutaneous injection 0.9% sodium chloride, given once</description>
        </group>
        <group group_id="E2">
          <title>Lidocaine</title>
          <description>1 ml subcutaneous injection of 0.9% lidocaine, given once</description>
        </group>
        <group group_id="E3">
          <title>Alkalinized Lidocaine</title>
          <description>1 ml subcutaneous injection of 0.9% lidocaine and 0.84% sodium bicarbonate</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Brian Wainger</name_or_title>
      <organization>Massachusetts General Hospital</organization>
      <phone>617-726-8810</phone>
      <email>bwainger@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

